Anti-p84 Antibody (56248)

Anti-p84 Antibody (56248)

Product No.: 56248

- -
- -
Clone
5.00E+10
Target
p84
Formats AvailableView All
Product Type
Monoclonal
Alternate Names
Tho1, Nuclear matrix protein p84, p84N5, hTREX84
Isotype
Mouse IgG2b
Applications
ICC
,
IF
,
IHC
,
IP
,
WB
,
Chromatin IP (ChIP)
,
IHC-P

- -
- -
Select Product Size

Data

Nuclear Matrix Protein p84 antibody [5E10] detects Nuclear Matrix Protein p84 protein at nucleus by immunohistochemical analysis. Sample: Paraffin-embedded human breast carcinoma. Nuclear Matrix Protein p84 stained by Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:200. Antigen Retrieval: Citrate buffer, pH 6.0, 15 minNuclear Matrix Protein p84 antibody [5E10] detects Nuclear Matrix Protein p84 protein at nucleus by immunohistochemical analysis. Sample: Paraffin-embedded human breast carcinoma. Nuclear Matrix Protein p84 stained by Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:200. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Detection of human p84/N5 in nuclear fraction by anti-p84/N5 5E10 monoclonal antibody (56248) in western blot experiment. Lane 1: total lysate, Lane 2: cytoplasmic fraction, Lane 3: membrane fraction, Lane 4: nuclear fraction.Detection of human p84/N5 in nuclear fraction by anti-p84/N5 5E10 monoclonal antibody (56248) in western blot experiment. Lane 1: total lysate, Lane 2: cytoplasmic fraction, Lane 3: membrane fraction, Lane 4: nuclear fraction.
Nuclear Matrix Protein p84 antibody [5E10] detects Nuclear Matrix Protein p84 protein at nucleus by immunofluorescent analysis. Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: Nuclear Matrix Protein p84 stained by Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:500. Red: phalloidin, a cytoskeleton marker, diluted at 1:100.Nuclear Matrix Protein p84 antibody [5E10] detects Nuclear Matrix Protein p84 protein at nucleus by immunofluorescent analysis. Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: Nuclear Matrix Protein p84 stained by Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:500. Red: phalloidin, a cytoskeleton marker, diluted at 1:100.
p84 antibody [5E10] immunoprecipitates p84 protein in IP experiments. IP Sample: HepG2 whole cell lysate/extract A : 30 ug whole cell lysate/extract of p84 protein expressing HepG2 cells B : Control with 3 ug of pre-immune mouse IgG C : Immunoprecipitation of p84 by 3 ug of p84 antibody [5E10] (56248) 7.5% SDS-PAGE The immunoprecipitated p84 protein was detected by p84 antibody [5E10] (56248) diluted at 1 : 1000. EasyBlot anti-rabbit IgG (HRP) was used as a secondary reagent.p84 antibody [5E10] immunoprecipitates p84 protein in IP experiments. IP Sample: HepG2 whole cell lysate/extract A : 30 ug whole cell lysate/extract of p84 protein expressing HepG2 cells B : Control with 3 ug of pre-immune mouse IgG C : Immunoprecipitation of p84 by 3 ug of p84 antibody [5E10] (56248) 7.5% SDS-PAGE The immunoprecipitated p84 protein was detected by p84 antibody [5E10] (56248) diluted at 1 : 1000. EasyBlot anti-rabbit IgG (HRP) was used as a secondary reagent.
Sample (30 ug of whole cell lysate) A: HeLa B: HeLa nucleus 7.5% SDS PAGE 56248 diluted at 1:1000 The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.Sample (30 ug of whole cell lysate) A: HeLa B: HeLa nucleus 7.5% SDS PAGE 56248 diluted at 1:1000 The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.
Sample (50 ug of whole cell lysate) A: mouse Cerebellum 7.5% SDS PAGE 56248 diluted at 1:1000 The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.Sample (50 ug of whole cell lysate) A: mouse Cerebellum 7.5% SDS PAGE 56248 diluted at 1:1000 The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.
Sample (whole cell lysate) A: 293T 20ug B: 293T 10ug C: 293T 5ug 7.5% SDS PAGE 56248 diluted at 1:1000 The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.Sample (whole cell lysate) A: 293T 20ug B: 293T 10ug C: 293T 5ug 7.5% SDS PAGE 56248 diluted at 1:1000 The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.
Nuclear Matrix Protein p84 antibody [5E10] detects Nuclear Matrix Protein p84 protein at nucleus by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Nuclear Matrix Protein p84 stained by Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:100. Antigen Retrieval: Citrate buffer, pH 6.0, 15 minNuclear Matrix Protein p84 antibody [5E10] detects Nuclear Matrix Protein p84 protein at nucleus by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Nuclear Matrix Protein p84 stained by Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:100. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min
Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:500. The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.Various whole cell extracts (30 ug) were separated by 7.5% SDS-PAGE, and the membrane was blotted with Nuclear Matrix Protein p84 antibody [5E10] (56248) diluted at 1:500. The HRP-conjugated anti-mouse IgG antibody was used to detect the primary antibody.
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Mouse
Immunogen
Fusion protein containing amino acids 15-374 of human p84 expressed in E. coli.
Product Concentration
Lot Specific
Formulation
PBS, pH 7.4.
State of Matter
Liquid
Product Preparation
Purified by Protein G affinity chromatography
Storage and Handling
This antibody is stable for at least one (1) year at -70°C. Avoid multiple freeze- thaw cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
Next Day 2-8°C
Applications and Recommended Usage?
Quality Tested by Leinco
Immunoblotting, immunoprecipitation, and

Immunofluorescence: use at 0.5-2 ug/mL.In immunoblots, a band of 84 kD is detected.

Positive controls: Lysates of Molt 4, HeLa, or Raji cells.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Specificity
This antibody recognizes an 84 kD nuclear matrix protein that was first discovered through its association with the N-terminal region of retinoblastoma protein.
Function
Required for efficient export of polyadenylated RNA. Acts as component of the THO subcomplex of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and which specifically associates with spliced mRNA and not with unspliced pre-mRNA. TREX is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NFX1 pathway. The TREX complex is essential for the export of Kaposi's sarcoma-associated herpesvirus (KSHV) intronless mRNAs and infectious virus production. Regulates transcriptional elongation of a subset of genes. Involved in genome stability by preventing co-transcriptional R-loop formation.; Participates in an apoptotic pathway which is characterized by activation of caspase-6, increases in the expression of BAK1 and BCL2L1 and activation of NF-kappa-B. This pathway does not require p53/TP53, nor does the presence of p53/TP53 affect the efficiency of cell killing. Activates a G2/M cell cycle checkpoint prior to the onset of apoptosis. Apoptosis is inhibited by association with RB1.
NCBI Gene Bank ID
UniProt.org
Research Area
Cancer Research

References & Citations

ICC
IF
IHC
Immunoprecipitation Protocol
General Western Blot Protocol
Chromatin IP (ChIP)
IHC-P

Certificate of Analysis

Formats Available

- -
- -
Prod No.
Description
56248
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.